Profil
Boris Minev formerly worked at Genelux Corp., as Director-Immunotherapy &Translational Oncology from 2010 to 2015, UCSD Moores Cancer Center, as Director-Tumor Immunology & Immunotherap from 2000 to 2015, and Calidi Biotherapeutics, Inc., as Chief Medical Officer & President-Medical Affairs from 2015 to 2025.
Dr. Minev received his doctorate degree from Medical University Sofia.
Ehemalige bekannte Positionen von Boris Minev
| Unternehmen | Position | Ende |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.07.2025 |
| GENELUX CORPORATION | Corporate Officer/Principal | 01.06.2015 |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical research services for cancer treatment | Corporate Officer/Principal | 01.06.2015 |
Ausbildung von Boris Minev
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical research services for cancer treatment | Commercial Services |
Medical University Sofia
Medical University Sofia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
















